Horizon Pharma plc Business Finance Contracts & Agreements

72 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Release and Waiver of Claims Agreement between Barry Moze and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2022
Release and Waiver of Claims and Non-Competition Agreement between Brian Beeler and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2022
Horizon Therapeutics plc 2014 Non-Employee Equity Plan
Equity Distribution Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2021
Third Supplemental Indenture to 5.500% Senior Notes Due 2027—Viela Bio, Inc., Horizon Therapeutics USA, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2021
Horizon Therapeutics plc Underwriting Agreement for 11,800,000 Ordinary Shares with Citigroup, Morgan Stanley, J.P. Morgan, Piper Sandler, and Stifel (August 6, 2020)
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2020
Second Supplemental Indenture to 5.500% Senior Notes Due 2027—Horizon Properties Holding LLC, Curzion Pharmaceuticals, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
First Supplemental Indenture to 5.500% Senior Notes Due 2027 between HZNP Finance Limited and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Release and Waiver of Claims Agreement between Robert F. Carey and Horizon Therapeutics PLC
Release Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Indenture for 5.500% Senior Notes Due 2027 between Horizon Pharma USA, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2019
Underwriting Agreement, dated March 6, 2019, by and among Horizon Pharma Public Limited Company and the several underwriters named therein
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2019
Seventh Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Third Supplemental Indenture, dated November 15, 2018, by and between Horizon Medicines LLC and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2019
Sixth Supplemental Indenture to 6.625% Senior Notes Due 2023 between Horizon Pharma USA, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fifth Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Services LLC, Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Fourth Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Tepro, Inc., Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Third Supplemental Indenture to 6.625% Senior Notes Due 2023—Raptor Pharmaceutical Corp., Raptor Pharmaceuticals Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture to 6.625% Senior Notes Due 2023—Horizon Pharma Rheumatology LLC, Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Second Supplemental Indenture among Horizon Pharma Services LLC, Horizon Pharma, Inc., and U.S. Bank National Association (Trustee)
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
First Supplemental Indenture to 8.750% Senior Notes Due 2024—Horizon Pharma Tepro, Inc., Horizon Pharma, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2018
Indenture for 8.750% Senior Notes Due 2024 between Horizon Pharma, Inc., Horizon Pharma USA, Inc., and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2016
First Supplemental Indenture among Horizon Pharma, Inc., Guarantors, and U.S. Bank National Association (May 7, 2015)
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
2015
Credit Agreement among Horizon Pharma, Inc., Horizon Pharma Public Limited Company, Subsidiary Guarantors, Lenders, and Citibank, N.A. (May 7, 2015)
Credit Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Indenture for 6.625% Senior Notes Due 2023 between Horizon Pharma Financing Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2015
Underwriting Agreement between Horizon Pharma Public Limited Company and Underwriters for Sale of Ordinary Shares
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Indenture for 2.50% Exchangeable Senior Notes due 2022 among Horizon Pharma Investment Limited, Horizon Pharma Public Limited Company, and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2015
Assignment and Option Agreement between InterMune Pharmaceuticals, Inc. and Connetics Corporation (June 23, 2000)
Assignment Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2015
Consent to Assignment Agreement among Genentech, Connetics, and InterMune Pharmaceuticals (June 23, 2000)
Assignment Agreements
Horizon Pharma plc
Pharmaceuticals
2015
Underwriting Agreement between Horizon Pharma Public Limited Company, Selling Shareholders, and Underwriters (November 13, 2014)
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2014
Temporary Escrow Agreement among Vidara Therapeutics Holdings LLC, Horizon Pharma, Inc., and Citibank, N.A.
Escrow Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2014
First Supplemental Indenture to 5.00% Convertible Senior Notes Due 2018 between Horizon Pharma, Inc., Horizon Pharma Public Limited Company, and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2014
Indenture Agreement for 5.00% Convertible Senior Notes due 2018 between Horizon Pharma, Inc. and U.S. Bank National Association
Indenture Agreements
Horizon Pharma plc
Pharmaceuticals
DE
2013
Underwriting Agreement between Horizon Pharma, Inc. and Underwriters for Sale of Units (Shares and Warrants)
Underwriting Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2012
Horizon Pharma, Inc. Warrant to Purchase Common Stock (Public Offering)
Warrant Agreements
Horizon Pharma plc
Pharmaceuticals
IL
2012
Incremental Amendment and Lender Joinder Agreement among Horizon Therapeutics USA, Inc., JPMorgan Chase Bank, N.A., and Citibank, N.A.
Credit Agreements
Horizon Pharma plc
Pharmaceuticals
2020
Horizon Therapeutics Public Limited Company 2014 Non-Employee Equity Plan, as amended, and Form of Option Agreement, Form of Stock Option Grant Notice, Forms of Restricted Stock...
Stock Agreements
Horizon Pharma plc
Pharmaceuticals
CA
2019
Horizon Pharma plc and Goodbody Trustees Limited Director Share Clog Program Trust Deed (2015)
Trust Agreements
Horizon Pharma plc
Pharmaceuticals
2016
Horizon Pharma plc and Goodbody Trustees Limited Director Share Clog Program Trust Deed (2015)
Trust Agreements
Horizon Pharma plc
Pharmaceuticals
2015
Amendment to Asset Purchase Agreement by and among Vidara Therapeutics and InterMune, Inc.
Purchase Agreements
Horizon Pharma plc
Pharmaceuticals
2015
Asset Purchase Agreement between Vidara Therapeutics and InterMune, Inc. dated May 17, 2012
Purchase Agreements
Horizon Pharma plc
Pharmaceuticals
WA
2015
Asset Purchase Agreement between AstraZeneca AB and Horizon Pharma USA, Inc. (November 18, 2013)
Purchase Agreements
Horizon Pharma plc
Pharmaceuticals
NY
2014